EditorialThe tumor microenvironment is a complex network of tumor cells, immune cells, stromal cells and extracellular matrix accomplishing proliferation, migration, and dissemination of tumor cells. The reactivity of the immune system towards the growing tumor determines its capacity to reject the tumor, but this reactivity is increasingly appearing to be critically dependent on tumor microenvironmental factors. These factors include secreted molecules, type of infiltrating cells, and metabolic component such as hypoxia. Microenvironmental hypoxia is a prominent feature of solid tumors and is involved in fostering the neoplastic process and in modulation of immune reactivity. It results from inadequacies between the tumor microcirculation and the oxygen demands of the growing tumor mass, which leads to a lowering of oxygen partial pressure and a metabolic switch towards glycolysis [1]. Tumor hypoxia is a negative prognostic and predictive factor due to many effects on the selection of hypoxiasurviving clones [2], activation of the expression of genes involved in apoptosis inhibition [3], angiogenesis [4], invasiveness and metastasis [5], epithelial-to-mesenchymal transition [6], and loss of genomic stability [7]. Accumulating evidence indicates that tumor hypoxia is also involved in loss of immune reactivity either by decreasing tumor cell sensitivity to cytotoxic effectors or promoting immunosuppressive mechanisms [8].The major effects of hypoxia are mediated through the stabilization of Hypoxia-inducible factors (HIFs) composed of a basic helix-loophelix/PAS protein (HIF-α) and the aryl hydrocarbon nuclear translocator (ARNT or HIF-ÎČ). Under normoxia, HIF-α subunit is degraded following hydroxylation at proline residues by prolylhydroxylases (PHD), which allows the binding of the E3 ubiquitin ligase pVHL for proteasome-targeted degradation [9][10][11]. Under normoxia, HIF-α is also hydroxylated at asparagine residues by the asparaginyl-hydroxylase Factor Inhibiting HIF-1 (FIH) to prevent interactions with co-activators such as p300 and aberrant transcriptional activation [10,11]. In contrast, the ÎČ-subunit is not regulated by oxygen levels and is constitutively expressed in the nucleus. Hypoxia inhibits the hydroxylation of proline and asparagine residues, allowing HIF-α nuclear translocation and binding to HIF-ÎČ for full transcriptional activation.Recently, we provided evidence indicating that hypoxia induced resistance of tumor cells to the lytic action of cytotoxic effector cells via several HIF-1α -dependent mechanisms involving activation of Stat3 [12] More interestingly, the expression of T cell inhibitory checkpoints was found to be regulated by hypoxic stress. We have recently shown that hypoxia induced up-regulation of Program Death-Ligand 1 (PD-L1), ligand of the inhibitory checkpoint PD-, on both tumor and Myeloid-Derived Suppressor Cells (MDSC) via direct binding of HIF-1 to PD-L1 promoter [19]. This establishes a direct link between immunosuppressive mechanisms and hypoxic signalling. Based on th...